Previously, mice engineered to express the disease-defining BCR-ABL translocation in hematopoietic stem cells were found to recapitulate chronic phase CML, with a small subset of tumors progressing to blast crisis (130). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.